Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali

PUBBLICAZIONI

Kondili LA, Brancaccio G, Tosti ME, Coco B, Quaranta MG, Messina V, Ciancio A, Morisco F, Cossiga V, Claar E, Rosato V, Ciarallo M, Cacciola I, Ponziani FR, Cerrito L, Coppola R, Longobardi F, Biliotti E, Rianda A, Barbaro F, Coppola N, Stanzione M, Barchiesi F, Fagiuoli S, Viganò M, Massari M, Russo FP, Ferrarese A, Laccabue D, Marco VD, Blanc P, Marrone A, Morsica G, Federico A, Ieluzzi D, Rocco A, Foschi FG, Soria A, Maida I, Chessa L, Milella M, Turco ERD, Madonia S, Chemello L, Gentile I, Toniutto P, Bassetti M, Surace L, Baiocchi L, Pellicelli A, De Santis A, Puoti M, Degasperi E, Niro GA, Zignego AL, Craxi A, Raimondo G, Santantonio TA, Brunetto MR, Gaeta GB, on behalf of PITER Collaborating Investigators. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and Delta cohort. Int J Infect Dis. 2024:107115. doi: 10.1016/j.ijid.2024.107115.

Quaranta MG, Cavalletto L, Russo FP, Calvaruso V, Ferrigno L, Zanetto A, Mattioli B, D’Ambrosio R, Panetta V, Brancaccio G, et al. Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER

HCV). Viruses. 2024; 16(5):682. https://doi.org/10.3390/v16050682

Andrea Marcellusi, Francesco Saverio Mennini, Massimo Andreoni, Loreta A. Kondili on behalf of PITER collaboration study group. Screening strategy to advance HCV elimination in Italy: a cost‑consequence analysis.The European Journal of Health Economics. 2024. https://doi.org/10.1007/s10198-023-01652-0

Kondili LA, Zanetto A, Quaranta MG, Ferrigno L, Panetta V, Calvaruso V, Zignego AL, Brunetto MR, Raimondo G, Biliotti E, Ieluzzi D, Iannone A, Madonia S, Chemello L, Cavalletto L, Coppola C, Morisco F, Barbaro F, Licata A, Federico A, Cerini F, Persico M, Pompili M, Ciancio A, Piscaglia F, Chessa L, Giacometti A, Invernizzi P, Brancaccio G, Benedetti A, Baiocchi L, Gentile I, Coppola N, Nardone G, Craxì A, Russo FP; PITER Collaborating Investigators. Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort. United European Gastroenterol J. 2023. doi: 10.1002/ueg2.12496.

Quaranta MG, Valle S, Mattioli B, Craxì L, Kondili L. Webinar. Dal decreto attuativo sullo screening HCV all’obiettivo di eliminazione. Notiziario dell’Istituto Superiore di Sanità. 2023; 36(10):11-14

Kondili LA, Craxì L, Nava F, Babudieri S, D’Ambrosio R, Marcellusi A, Mennini FS, Valle S, Russo P, Olimpieri PP, Andreoni M, Aghemo A.
From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy.
J Infect Dis. 2023 Sep 13;228(Suppl 3):S211-S220. doi.org/10.1093/infdis/jiad038J Infect Dis. 2023 Sep 13;228(Suppl 3):S211-S220. doi.org/10.1093/infdis/jiad038

Brancaccio G, Coco B, Nardi A, Quaranta MG, Tosti ME, Ferrigno L, Cacciola I, Messina V, Chessa L, Morisco F, Milella M, Barbaro F, Ciancio A, Russo FP, Coppola N, Blanc P, Claar E, Verucchi G, Puoti M, Zignego AL, Chemello L, Madonia S, Fagiuoli S, Marzano A, Ferrari C, Lampertico P, Di Marco V, Craxì A, Santantonio TA, Raimondo G, Brunetto MR, Gaeta GB, Kondili LA; PITER Collaborating Investigators.
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination
Int J Infect Dis. 2023;129:266-273. doi: 10.1016/j.ijid.2023.02.006

Kondili LA, Quaranta MG, Cavalletto L, Calvaruso V, Ferrigno L, D’Ambrosio R, Simonelli I, Brancaccio G, Raimondo G, Brunetto MR, Zignego AL, Coppola C, Iannone A, Biliotti E, Verucchi G, Massari M, Licata A, Barbaro F, Persico M, Russo FP, Morisco F, Pompili M, Viganò M, Puoti M, Santantonio T, Villa E, Craxì A, Chemello L; PITER Collaborating Investigators.
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort
Dig Liver Dis. 2023:S1590-8658(23)00164-0. doi: 10.1016/j.dld.2023.01.153

LA Kondili, MG Quaranta, L Craxì, S Babudieri, I Grattagliano, C Leonardi, F Nava, FS Mennini, M Andreoni, L Bertinato.
Implementare le politiche sanitarie a livello regionale per l’eliminazione dell’epatite C ai tempi del Covid-19
Notiziario dell’Istituto Superiore di Sanità. 2022. 35:3-8

Kondili LA, Monti M, Quaranta MG, Gragnani L, Panetta V, Brancaccio G, Mazzaro C, Persico M, Masarone M, Gentile I, Andreone P, Madonia S, Biliotti E, Filomia R, Puoti M, Fracanzani AL, Laccabue D, Ieluzzi D, Coppola C, Rumi MG, Benedetti A, Verucchi G, Coco B, Chemello L, Iannone A, Ciancio A, Russo FP, Barbaro F, Morisco F, Chessa L, Massari M, Blanc P, Zignego AL.
A prospective study of DAA Effectiveness and Relapse Risk in HCV Cryoglobulinemic Vasculitis by the Italian PITER Cohort
Hepatology. 2021 Dec 16. doi: 10.1002/hep.32281.

A Marcellusi, C Simonelli, FS Mennini, LA Kondili on behalf of PITER Collaborating Group.
Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis
Applied Health Economics and Health Policy. doi: 10.1007.

LA Kondili, A. Aghemo, M. Andreoni.
Challenges on the achievement of world health organizations goals for HCV elimination in Italy: need for a regional programmatic approach on screening and linkage to care
Annali dell’Istituto Superiore di Sanità. 2021; 57(3): 201-204.

MG Quaranta, L Ferrigno, X Tata, F D’Angelo, C Coppola, A Ciancio, SR Bruno, M Loi, A Giorgini, M Margotti, V Cossiga, G Brancaccio, M Dallio, M De Siena, M Cannizzaro, L Cavalletto, M Massari, M Mazzitelli, P De Leo, D Laccabue, L Baiocchi, LA Kondili.
Liver function following Hepatitis C Virus eradication by Direct Acting Antivirals in patients with liver cirrhosis: data from the PITER cohort
BMC Infectious Diseases. 2021. 21(1):413. doi: 10.1186/s12879-021-06053-3.

Loreta A. Kondili, Alessio Aghemo, Massimo Andreoni, Massimo Galli, Alessandro Rossi, Sergio Babudieri, Felice Nava, Claudio Leonardi, Francesco Saverio Mennini, Ivan Gardini Francesco Paolo Russo.
Milestones to reach Hepatitis C Virus (HCV) elimination in Italy: From free-of-charge screening to regional roadmaps for an HCV-free nation
Digestive Liver Disease. 2021. S1590-8658(21)00142-0. doi: 10.1016/j.dld.2021.03.026.Online ahead of print.

MG Quaranta, L Ferrigno, X Tata, F D’Angelo, M Massari, C Coppola, E B, A Giorgini, D Laccabue, A Ciancio, PL Blanc, M Margotti, D Ieluzzi, MR Brunetto, F Barbaro, FP Russo, I Beretta, G Morsica, G Verucchi, A Saracino, M Galli, LA Kondili on behalf of PITER Collaborating Group.
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: a real-life evaluation of the PITER cohort
Digestive and Liver Diseases. 2021. S1590-8658(21)00137-7. doi: 10.1016/j.dld.2021.03.020. Online ahead of print.

FS Mennini, A Marcellusi, S Robbins Scott, S Montilla, A Craxì, Buti M, Gheorghe, S Ryder, LA Kondili.
The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries
Liver Int. 2021. doi: 10.1111/liv.14796.

LA Kondili, A Craxì, A Aghemo.
Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements
Liver Int. 2021. doi: 10.1111/liv.14796.

LA Kondili, MG Quaranta, L Ferrigno, M Galli, M Andreoni, M. Puoti, S. Petta, A. Craxì, S. Vella, A Marcellusi, C. Simonelli, I. Gamkrelidze, S Blach, H Razavi, FS Mennini per Gruppo Collaborativo della Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali (PITER).
Eliminazione dell’Epatite C cronica in Italia: strategie di screening gratuito
Notiziario dell’Istituto Superiore di Sanità 2021. 34:3-8.

S Blach, LA Kondili, A Aghemo, Z Cai, E Dugan, C Estes, I Gamkrelidze, S Ma, JM Pawlotsky, D Razavi-Shearer, H Razavi, I Waked, S Zeuzem, A Craxì.
Impact of COVID-19 on global hepatitis C elimination efforts
Journal of Hepatology. 2020:S0168-8278(20)30523-7. doi: 10.1016/j.jhep.2020.07.042.

LA Kondili, A Marcellusi, S Ryder, A Craxì.
Will the COVID-19 pandemic affect HCV disease burden?
Digestive and Liver Disease. 2020;52:947-949. doi: 10.1016/j.dld.2020.05.040.

LA Kondili, S Blach, H Razavi, A Craxì.
Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road to hepatitis C virus elimination?
Annali dell’Istituto Superiore di Sanità. 2020;56:325-329. doi: 10.4415/ANN_20_03_10.

MG Quaranta, L Ferrigno, M Monti, R Filomia, E Biliotti, A Iannone, G Migliorino, B Coco, F Morisco, M Vinci, R D’Ambrosio, L Chemello, M Massari, D Ieluzzi, FP Russo, P Blanc, G Verucchi, M Puoti, MG Rumi, F Barbaro, TA Santantonio, A Federico, L Chessa, I Gentile, M Zuin, G Parruti, G Morsica, LA Kondili on behalf of PITER Collaborating Group.
Advanced liver disease outcomes after Hepatitis C eradication by Human Immunodeficiency Virus infection in PITER cohort
Hepatology International. 2020. doi: 10.1007/s12072-020-10034-0.

MG Quaranta, S Rosato, L Ferrigno, DC Amoruso, M Monti, P Di Stefano, R Filomia, E Biliotti, G Migliorino, FP Russo, E Degasperi, L Chemello, G Brancaccio, P Blanc, M Cannizzaro, F Barbaro, G Morsica, A Licata, LA Kondili on behalf of PITER collaborating group.
Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohort
Antiviral Therapy. 2020. doi: 10.3851/IMP3350

LA Kondili, I Gamkrelidze, S Blach, A Marcellusi, M Galli, S Petta, M Puoti, S Vella, H Razavi, A Craxì, F Mennini, PITER collaborating group.
Optimization of hepatitis C virus screening strategies by birth cohort in Italy
Liver International. 2020. doi: 10.1111/liv.14408

A Marcellusi, R Viti, LA Kondili, S Rosato, S Vella, FS Mennini, PITER collaborating group.
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data
Pharmacoeconomics. 2019;37:255-266

LA Kondili, S Robbins, S Blach, I Gamkrelidze, AL Zignego, MR Brunetto, G Raimondo, G Taliani, A Iannone, FP Russo, TA Santantonio, M Zuin, L Chessa, P Blanc, M Puoti, M Vinci, EM Erne, M Strazzabosco, M Massari, P Lampertico, MG Rumi, A Federico, A Orlandini, A Ciancio, G Borgia, P Andreone, N Caporaso, M Persico, D Ieluzzi, S Madonia, A Gori, A Gasbarrini, C Coppola, G Brancaccio, A Andriulli, MG Quaranta, S Montilla, H Razavi, M Melazzini, S Vella, A Craxì, PITER collaborating group.
Forecasting Hepatitis C liver disease burden on real life data. Does the hidden iceberg matter to reach the elimination goals?
Liver International. 2018;38:2190-2198

Gruppo Collaborativo della Piattaforma Italiana per lo Studio della Terapia delle Epatiti Virali (PITER) e Alta Scuola di Economia e Management dei Sistemi Sanitari (ALTEMS).
L’Italia come modello per l’Europa e per il mondo nelle politiche sanitarie per il trattamento dell’epatite cronica da HCV
Notiziario dell’Istituto Superiore di Sanità. 2018. 31(1):3-7

LA Kondili, S Vella, AL Zignego, PITER collaborating Group.
Mixed cryoglobulinemia: an important but frequently unrecognized and underestimated HCV-related condition in the real life practice
Liver International. 2018;38:183

LA Kondili, GB Gaeta, MR Brunetto, A Di Leo, A Iannone, TA Santantonio, A Giammario, G Raimondo, R Filomia, C Coppola, DC Amoruso, P Blanc, B Del Pin, L Chemello, L Cavalletto, F Morisco, L Donnarumma, MG Rumi, A Gasbarrini, M Siciliano, M Massari, R Corsini, B Coco, Madonia, M Cannizzaro, AL Zignego, M Monti, FP Russo, A Zanetto, M Persico, M Masarone, E Villa, V Bernabucci, G Taliani, E Biliotti, L Chessa, MC Pasetto, P Andreone, M Margotti, G Brancaccio, D Ieluzzi, G Borgia, E Zappulo, V Calvaruso, S Petta, L Falzano, MG Quaranta, LE Weimer, S Rosato, S Vella, EG Giannini.
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: interim evaluations from the PITER network
PLoS One 2017. doi: 10.1371/journal.pone.0185728

A Karampatou, X Han, LA Kondili, G Taliani, A Ciancio, F Morisco, RM Critelli, E Baraldi, V Bernabucci, G Troshina, M Guarino, S Tagliavini, F D’Ambrosio, L Bristot, L Turco, S Rosato, S Vella, T Trenti, I Neri, A La Marca, S Manthena, AS Goldstein, S Bruno, Y Bao, YS Gonzalez, E Villa; PITER framework investigators.
Premature ovarian senescence and high miscarriage rate impair fertility in women with hepatitis C virus infection
Journal of Hepatology. 2017;68:3341

LA Kondili, F Romano, FR Rolli, M Ruggeri, S Rosato, MR Brunetto, AL Zignego, A Ciancio, A Di Leo, G Raimondo, C Ferrari, G Taliani, G Borgia, TA Santantonio, P Blanc, GB Gaeta, A Gasbarrini, L Chessa, EM Erne, E Villa, D Ieluzzi, FP Russo, P Andreone, M Vinci, C Coppola, L Chemello, S Madonia, G Verucchi, M Persico, M Zuin, M Puoti, A Alberti, G Nardone, M Massari, G Montalto, G Foti, MG Rumi, MG Quaranta, A Cicchetti, A Craxì, S Vella on behalf of PITER Collaborating Group.
Modelling cost-effectiveness and health gains of a “universal” vs. “prioritized” HCV treatment policy in a real-life cohort
Hepatology. 2017;66:1814-1825

LA Kondili, GB Gaeta, D Ieluzzi, AL Zignego, M Monti, A Gori, A Soria, G Raimondo, R Filomia, A Di Leo, A Iannone, M Massari, R Corsini, R Gulminetti, A Gatti Comini, P Toniutto, D Dissegna, FP Russo, A Zanetto, MG Rumi, G Brancaccio, E Danieli, MR Brunetto, LE Weimer, MG Quaranta, S Vella, M Puoti.
Real-life data on potential drug-drug interactions in patients with chronic Hepatitis C viral infection undergoing antiviral therapy with Interferon-free DAAs in the PITER Cohort Study
PLoS One 2017. 12:e0172159. doi: 10.1371/journal.pone.0172159

LA Kondili, S Vella and PITER Collaborating Group.
PITER: An ongoing nationwide study on the real-life impact of direct acting antiviral based treatment for chronic hepatitis C in Italy
Digestive and Liver Disease 2015. 47:741-743

LA Kondili, L Falzano, A Mallano, MG Quaranta, M Mirra, LE Weimer, L Fucili, M Di Gregorio, S Lucattini, M Massella, R Terlizzi, E Olivieri, F Magnani, A Mattei, S Rosato, ME Tosti, S Vella e Rete Collaborativa dei Centri Clinici PITER.
La Piattaforma Italiana per lo Studio della Terapia delle Epatiti Virali (PITER): il primo grande studio nazionale sull’infezione cronica da virus dell’epatite C
Notiziario dell’Istituto Superiore di Sanità 2015. 28:3-10

LA Kondili, MG Quaranta, L Falzano, A Mallano, M Mirra, LE Weimer, L Fucili, M Di Gregorio, S Lucattini, M Massella, R Terlizzi, E Olivieri, F Magnani, A Mattei, S Rosato, ME Tosti, S Vella and PITER Collaborating Group.
PITER-HCV cohort study as part of the Italian platform for the study of viral hepatitis therapies
Rapporti ISTISAN 2015. 15/35, vii, 39

LA Kondili, G Brancaccio, ME Tosti, B Coco, MG Quaranta, V Messina, A Ciancio, F Morisco, V Rosato, M Ciarallo, I Cacciola, MR Brunetto, GB Gaeta on behalf of PITER Collaborating Investigators. Clinical profile of patients with chronic HDV infection by the nationwide Italian PITER-cohort. The 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL). Kyoto, 27-31 Marzo 2024

LA Kondili, A Zanetto, MG Quaranta, L Ferrigno, V Panetta, V Calvaruso, AL Zignego, MR Brunetto, G Raimondo, E Biliotti, D Ieluzzi, A Iannone, S Madonia, L Chemello, L Cavalletto, C Coppola, F Morisco, F Barbaro, A Licata, A Federico, M Viganò, M Persico, M Pompili, A Ciancio, F Piscaglia, L Chessa, A Giacometti, P Invernizzi, G Brancaccio, A Benedetti, L Baiocchi, I Gentile, N Coppola, G Nardone, A Craxì, FP Russo, PITER Collaborating Investigators. Incidence and predictive factors of portal vein thrombosis in patients with HCV-related cirrhosis after sustained virological response: long term competing risk analysis in the PITER cohort. The Liver Meeting, AASLD 2023. Boston, 10-14 Novembre 20123

MG Quaranta, L Ferrigno, ME Tosti, L Kondili on behalf of PITER Collaborating Group. MASLD and chronic viral hepatitis: baseline results from patients enrolled in the PITER HCV and HBV and HDV Italian cohorts. EASL SLD Summit 2023. Praga, 21-23 Settembre 2023

L.A. Kondili, M.E. Tosti, M.G. Quaranta, A. Ciancio, V. Messina, G. Brancaccio, M.R. Brunetto, M. Capasso, V. Rosato, I. Cacciola, L. Pasulo, T.A. Santantonio, C. Coppola, E. Biliotti, F. Barbaro, M. Massari, N. Coppola, A. Ferrarese, F.P. Russo, V. Di Marco, A. Marrone, S. Schivazzappa, A. Federico, P. Blanc, A. Rocco, G. Morsica, D. Ieluzzi, F. Conti, M. De Siena, M.G. Bavetta, M. Milella, I. Gentile, C. Porcu, L. Chemello, M. Marracci, A.L. Zignego, L. Baiocchi, I. Maida, B. Coco on Behalf of PITER Collaborating Group. Epidemiological and clinical profile of HDV infected people in care in Italy: interim analysis from the ongoing PITER cohort. The International Liver Congress™ 2023. 58nd annual meeting of the European Association for the Study of the Liver (EASL). Vienna 21-24 Giugno 2023

PITER Collaborating Investigators.

Epidemiological and clinical profile of HDV infected people in care in italy: interim analysis from the ongoing PITER cohort
Riunione Annuale AISF 2023. Roma, 16-17 Marzo 2023

A. Marcellusi, K. Tata, F.S. Mennini, M. Andreoni, L.A. Kondili.
Need to implement the screening strategy to advance HCV elimination in Italy: a cost-consequences analysis
The International Liver Congress 2022. 57nd annualmeeting of the European Association for the Study of the Liver (EASL). Londra 22-26 Giugno 2022

L.A. Kondili, M.G. Quaranta, L. Ferrigno, C. Coppola, M. Monti, R. Filomia, G. Brancaccio, M.R. Brunetto, E. Biliotti, D. Ieluzzi, A. Iannone, S. Madonia, X. Tata, L. Cavalletto, V. Cossiga, S. Amodeo, V. Calvaruso, E. Rosselli del Turco, M.G. Rumi, M. Pompili, A. Ciancio, L. Brescini, F.P. Russo.
De-novo occurrence of portal vein thrombosis in patients with HCV-related cirrhosis after sustained virological response: medium to long term observations from the ongoing PITER cohort
The International Liver Congress 2022. 57nd annual meeting of the European Association for the Study of the Liver (EASL). Londra 22-26 Giugno 2022

L.A. Kondili, M.G. Quaranta, L. Ferrigno, C. Coppola, M. Monti, R. Filomia, G. Brancaccio, M.R. Brunetto, E. Biliotti, D. Ieluzzi, A. Iannone, S. Madonia, X. Tata, L. Cavalletto, V. Cossiga, S. Amodeo, V. Calvaruso, E. Rosselli del Turco, M.G. Rumi, M. Pompili, A. Ciancio, L. Brescini, F.P. Russo.
De-novo occurrence of portal vein thrombosis in patients with HCV-related cirrhosis after sustained virological response: medium to long term observations from the ongoing PITER cohort
Riunione Annuale AISF 2022. Roma, 24-25 Marzo 2022

B. Coco, M.E. Tosti, G. Raimondo, C. Coppola, L. Chessa, T. Santantonio, G.B. Gaeta, G. Brancaccio, A. Marzano, M. Milella, V. Messina, F.P. Russo, A.M. Cattelan, P. Lampertico, E. Claar, P.L. Blanc, F. Morisco, G. Verucchi, D. Ieluzzi, S. Madonia, L. Chemello, M.G. Rumi, C. Torti, G. Morsica, A. Federico, A. Giorgini, A.L. Zignego, M. Anselmo, A. Colecchia, P. Toniutto, F. Piscaglia, A. Ciancio, M. Puoti, N. Coppola, G.F. Foschi, G. Nardone, G. D’Offizi, F. Castelli, C. Mazzaro, A. Mastroianni, A. Licata, I. Maida, G. Di Perri, V. Di Marco, M.G. Quaranta, L.A. Kondili.
Epidemiological, virological and clinical profile of HBsAg positive individuals in Italian hospital settings: interim results of the HBV/HDV PITER cohort
Riunione Annuale AISF 2022. Roma, 24-25 Marzo 2022

A. Marcellusi, C. Simonelli, F.S. Mennini, L.A. Kondili, on behalf of PITER Collaborating group available at www.progettopiter.it.
Economic consequences of anti-HCV treatment of patients diagnosed through screening in Italy: a prospective modelling analysis
7° Convegno Nazionale ISPOR Italy-Rome Chapter. 13-14 Dicembre 2021

A. Marcellusi, C. Simonelli, F.S. Mennini, L.A. Kondili, on behalf of PITER Collaborating group available at www.progettopiter.it
Economic consequences of anti-HCV treatment of patients diagnosed through screening in Italy: a prospective modelling analysis
Virtual ISPO Europe 2021 30 Novembre-3 Dicembre 2021

LA Kondili, MG Quaranta, L Cavalletto, L Ferrigno, C Coppola, DC Amoruso, G Brancaccio, G. Raimondo, R Filomia, MR. Brunetto, B Coco, AL Zignego, M Monti, A Iannone, S Madonia, D Ieluzzi, G Taliani, E Biliotti, G Verucchi, L Badia, G Migliorino, I Beretta, M Massari, A Licata, A R Capitano, F Barbaro, M Zuin, A Giorgini, M Persico, M Masarone, F P Russo, A Zanetto, F Morisco, V Cossiga, P Blanc, P Pierotti, A Craxì, V Calvaruso, L Chemello on behalf of PITER Collaborating Group.
De novo hepatocellular carcinoma occurrence following the HCV viral eradsication by direct acting antivirals (DAA): medium to long term observations from the ongoing PITER cohort
The Liver Meeting, AASLD 2021 12-15 Novembre 2021

A Marcellusi, FS Mennini, M Ruf, C Galli, A Aghemo, MR Brunetto, S Babudieri, A Craxi, M Andreoni, LA Kondili.
Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation
The International Liver Congress 2021. Annual meeting of the European Association for the Study of the Liver (EASL). 23-26 Giugno 2021

MG Quaranta, L Ferrigno, M Monti, R Filomia, E Biliotti, A Iannone, G Migliorino, B Coco, F Morisco, M Vinci, R D’Ambrosio, L Chemello, M Massari, D Ieluzzi, FP Russo, P Blanc, G Verucchi, M Puoti, MG Rumi, F Barbaro, TA Santantonio, A Federico, L Chessa, I Gentile, M Zuin, G Parruti, G Morsica, LA Kondili on behalf of PITER Collaborating Group.
Advanced liver disease outcomes after Hepatitis C viral eradication according to Human Immunodeficiency Virus coinfection in PITER cohort
12° Congresso Nazionale ICAR “Italian Conference on AIDS and Antiviral Research, Digital Edition 12-16 ottobre 2020

X Tata, A Marcellusi, G Fabiano, S Ryder, M Buti, L Gheorghe, C Coppola, A Craxì, FS Mennini, LA Kondili.
Clinical and economic consequences of antiviral treatment for Hepatitis C chronic infection in Europe: analysis of England, Italy, Romania and Spain data
The Digital International Liver Congress™ 2020. 55th Annual meeting of the European Association for the Study of the Liver (EASL). 27-29 Agosto 2020

R Rossotti, A Tavelli, MG Quaranta, L Ferrigno, F Bai, F Barbaro, A Cingolani, M Dallio, M Loi, E Zappullo, A d’Arminio Monforte, M Puoti.
HIV/HCV co-infected subjects show better thrombocytopenia improvement after SVR achievement than HCV mono-infected cirrhotics. Data from the HepaICONA and PITER cohorts
The Digital International Liver Congress™ 2020. 55th Annual meeting of the European Association for the Study of the Liver (EASL). 27-29 Agosto 2020

LA Kondili, MG Quaranta, M Monti, DC Amoruso, R Filomia, E Biliotti, A Iannone, D Ieluzzi, B Coco, FP Russo, I Beretta, G Parruti, P Blanc, M Vinci, V Cossiga, E Degasperi, L Chemello, M Massari, L Badia, M Puoti, SR Bruno, M De Siena, V Panetta, A Aghemo.
The weight of pre-existing cofactors for liver disease progression in patients who successfully eradicated HCV virus infection: An interim analysis in the PITER cohort
The Digital International Liver Congress™ 2020. 55th Annual meeting of the European Association for the Study of the Liver (EASL). 27-29 Agosto 2020

LA Kondili, MG Quaranta, M Monti, DC Amoruso, R Filomia, E Biliotti, A Iannone, D Ieluzzi, B Coco, FP Russo, I Beretta, G Parruti, P Blanc, M Vinci, V Cossiga, E Degasperi, L Chemello, M Massari, L Badia, M Puoti, SR Bruno, M De Siena, V Panetta, A Aghemo.
The weight of pre-existing cofactors for liver disease progression in patients who successfully eradicated HCV virus infection: An interim analysis in the PITER cohort
53nd Annual Meeting of the Italian Association for the Study of the Liver (AISF). Roma, 27-28 Febbraio 2020

LA Kondili, M Monti, G Ferrante, MG Quaranta, F Madia, M Vinci, G Borgia, G Brancaccio, B Coco, M Margotti, L Chemello, A Ciancio, MG Rumi, M Puoti, S Madonia, AL Fracanzani, M Persico, R Filomia, E Biliotti, A Benedetti, E Negri, D Ieluzzi, C Coppola, TA Santantonio, AL Zignego and PITER Collaborating Group.
Long term effectiveness of DAA therapy in patients with chronic HCV and Mixed Cryoglobulinemic Syndrome
XVIII Congresso Nazionale SIMIT, Palermo, 24-27 Novembre 2019

MG Quaranta, L Ferrigno, F D’Angelo, C Viscoli, G Morsica, P Blanc, M Puoti, M Massari, G Verucchi, L Chessa, L Kondili and PITER Collaborating Group.
Outcomes of advanced liver disease in patients with chronic hepatitis C with and without HIV coinfection following sustained virological response: a real life evaluation in the PITER cohort
XVIII Congresso Nazionale SIMIT, Palermo, 24-27 Novembre 2019

LA Kondili, I Gamkrelidze, S Blach, A Marcellusi, M Galli, S Petta, M Puoti, S Vella, A Craxì, H Razavi, FS Mennini on behalf of PITER collaborating group.
Optimization of Hepatitis C Virus screening strategies by birth cohort in Italy
XVIII Congresso Nazionale SIMIT, Palermo, 24-27 Novembre 2019

LA Kondili, M Monti, G Ferrante, MG Quaranta, F Madia, M Vinci, G Borgia, G Brancaccio, B Coco, M Margotti, L Chemello, A Ciancio, MG Rumi, M Puoti, S Madonia, AL Fracanzani, M Persico, R Filomia, E Biliotti, A Benedetti, E Negri, D Ieluzzi, C Coppola, TA Santantonio, AL Zignego and PITER Collaborating Group.
Long term effectiveness of DAA therapy in patients with chronic HCV and Mixed Cryoglobulinemic Syndrome
The Liver Meeting, AASLD 2019. Boston, 8-12 Novembre 2019

MG Quaranta, L Ferrigno, F D’Angelo, C Viscoli, G Morsica, P Blanc, M Puoti, M Massari, G Verucchi, L Chessa, L Kondili and PITER Collaborating Group.
Outcomes of advanced liver disease in patients with chronic hepatitis C with and without HIV coinfection following sustained virological response: a real life evaluation in the PITER cohort
The Liver Meeting, AASLD 2019. Boston, 8-12 Novembre 2019

G Ferrante, LA Kondili, M Monti, MG Quaranta, F Madia, M Vinci, G Borgia, G Brancaccio, B Coco, AL Zignego.
Efficacia a lungo termine dei farmaci ad azione diretta nei pazienti con epatite C cronica e sindrome crioglobulinemica
53° Convegno Associazione Italiana di Epidemiologia (AIE). Catania, 24 Ottobre 2019

LA Kondili, MG Quaranta, A Marcellusi, A Craxì, M Puoti, I Gamkrelidze, S Blach, H Razavi, FS Mennini, and PITER Collaborating Group.
Screening strategies for hepatitis C virus elimination in Italy
ICAR 2019. XI Italian conference on AIDS and Antiviral Research, Milano, 5-7 Giugno 2019

I Gamkrelidze, L Kondili, A Marcellusi, S Robbins, S. Blach, A Craxì, M Puoti, H Razavi, FS Mennini.
Screening strategies for hepatitis C virus elimination in Italy
The International Liver Congress™ 2019. 54th Annual meeting of the European Association for the Study of the Liver (EASL). Vienna 10-14 Aprile 2019

C Estes, L Kondili, MG Quaranta, A Craxì, S Petta, M Masarone, FP Russo, M Siciliano, B Coco, R Filomia, H Razavi.
Modeling NAFLD-Related Disease Progression among the PITER SVR12 Cohort
The International Liver Congress™ 2019. 54th Annual meeting of the European Association for the Study of the Liver (EASL). Vienna 10-14 Aprile 2019

MG Quaranta, S Rosato, L Ferrigno, DC Amoruso, M Monti, P Di Stefano, R Filomia, F Tamburini, G Migliorino, A Zanetto, E Degasperi, L Cavalletto, G Brancaccio, P Blanc, M Cannizzaro, E Castelli, G Morsica, A Licata, LA Kondili.
Real life data on elbasvir/grazoprevir efficacy, safety and drug-drug interaction profile in patients with chronic hepatitis C viral infection: a prospective analysis in the PITER cohort
The International Liver Congress™ 2019. 54th Annual meeting of the European Association for the Study of the Liver (EASL). Vienna 10-14 Aprile 2019

MG Quaranta, S Rosato, L Ferrigno, DC Amoruso, M Monti, P Di Stefano, R Filomia, F Tamburini, G Migliorino, A Zanetto, E Degasperi, L Cavalletto, G Brancaccio, P Blanc, M Cannizzaro, E Castelli, G Morsica, A Licata, LA Kondili on behalf of PITER collaborating group.
Real life data on elbasvir/grazoprevir efficacy, safety and drug-drug interaction profile in patients with chronic hepatitis C viral infection: a prospective analysis in the PITER cohort
52nd Annual Meeting of the Italian Association for the Study of the Liver. Roma 21-22 Febbraio 2019

LA Kondili, A Marcellusi, I Gamkrelidze, S.Blach, S Robbins, A Craxì, M Puoti, S Vella, H Razavi, FS Mennini
Screening strategies for Hepatitis C Virus elimination in Italy
52nd Annual Meeting of the Italian Association for the Study of the Liver. Roma 21-22 Febbraio 2019

MG Quaranta, A Marcellusi, R Viti, L Ferrigno, DC Amoruso, M Monti, B Coco, R Filomia, S Bruno, A Iannone, E Biliotti, A Giorgini, M Loi, V Calvaruso, AR Buonomo, V Guarneri, A Zanetto, F Baragli, V Cossiga, MC Gizzi, E Castelli, M Cannizzaro, D Ieluzzi, M Vinci, M Masarone, L Cavalletto, R Corsini, A Licata F Mennini, L Kondili, e Gruppo collaborativo PITER.
Analisi modellistica sulle conseguenze cliniche ed economiche del trattamento antivirale contro l’infezione cronica da HCV nella coorte reale PITER
XVII Congresso Nazionale SIMIT, Torino, 2-5 Dicembre 2018

LA Kondili, MG Quaranta, S Rosato, LE Weimer, F D’Angelo, C Coppola, AL Zignego, MR Brunetto, G Raimondo, TA Santantonio, A Iannone, G Taliani, M Zuin, L Chessa, A Craxì, G Borgia, P Andreone, FP Russo, P Blanc, F Morisco, G Parruti, F Barbaro, S Madonia, F Capra, M Vinci, M Persico, L Chemello, A Gori, M Massari, M Puoti, A Licata, E Villa e Gruppo Collaborativo PITER.
Fattori predittivi della progressione della malattia del fegato in pazienti con risposta sierologica sostenuta indotta dai DAA: dati della coorte reale PITER
XVII Congresso Nazionale SIMIT, Torino, 2-5 Dicembre 2018

LA Kondili, MG Quaranta, S Rosato, LE Weimer, F D’Angelo, C Coppola, AL Zignego, MR Brunetto, G Raimondo, TA Santantonio, A Iannone, G Taliani, M Zuin, L Chessa, A Craxì, G Borgia, P Andreone, FP Russo, P Blanc, F Morisco, G Parruti, F Barbaro, S Madonia, F Capra, M Vinci, M Persico, L Chemello, A Gori, M Massari, M Puoti, A Licata, E Villa and PITER collaborating Group.
Predictive Factors for Liver Disease Progression Following the Direct Acting Antivirals Induced Sustained Virological Response: Data from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER) Cohort
The Liver Meeting, AASLD 2018. San Francisco, 9-13 Novembre 2018 (POSTER of DISTINCTION)

LA Kondili, A Marcellusi, R Viti, MG Quaranta, L Ferrigno, DC Amoruso, M Monti, B Coco, R Filomia, S Bruno, A Iannone, E Biliotti, A Giorgini, M Loi, V Calvaruso, AR Buonomo, V Guarneri, A Zanetto, F Baragli, V Cossiga, MC Gizzi, E Castelli, M Cannizzaro, D Ieluzzi, M Vinci, M Masarone, L Cavalletto, R Corsini, A Licata, F Mennini and PITER collaborating Group.
Epidemiological and economic evaluations according to DAA treatment access in Italy based on real life PITER cohort data
The Liver Meeting, AASLD 2018. San Francisco, 9-13 Novembre 2018

R Viti, A Marcellusi, L Kondili, S Rosato, S Vella, FS Mennini.
Economic consequences of anti-HCV antiviral treatment investment from the NHS perspective
12th European Conference on Health Economics (EuHEA), MECC Maastricht, the Netherlands,11-14 Luglio 2018

S Vella, L Kondili, A Marcellusi , R Viti, S Rosato, MG Quaranta, ME Tosti, L Ferrigno, F Mennini.
Epidemiological and economic evaluations according to DAA treatment access: an interim evaluation based on PITER cohort data
ISHEID 2018. Marsiglia 13-15 Maggio 2018

LA Kondili, S Robbins, S Blach, I Gamkrelidze, AL Zignego, MR Brunetto, G Raimondo, G Taliani, A Iannone, FP Russo, T Santantonio, M Zuin, L Chessa, PL Blanc, M Puoti, M Vinci, EM Erne, M Strazzabosco, M Massari, P Lampertico, MG Rumi, A Federico, C Ferrari, A Ciancio, G Borgia, P Andreone, N Caporaso, M Persico, D Ieluzzi, A Gori, A Gasbarrini, C Coppola, G. Brancaccio, A Andriulli, S Montilla, H Razavi, M Melazzini, S Vella, A Craxì on behalf of PITER collaborating group.
Forecasting Hepatitis C liver disease burden based on real life data. Does the hidden iceberg matter to reach the World Health Organization elimination goals?
ICAR 2018. X Italian conference on AIDS and Antiviral Research, Roma, 22-24 Maggio 2018

A Saracino, D Bavaro, S Rosato, A Giorgini, R Corsini, E Castelli, M Vinci, F Baragli, E Biliotti, A Orlandini, M Monti, A Zanetto, C Baiguera, G Morsica, A Soria, S Bruno, A Ciancio, V Donati, V Calvaruso, MG Quaranta on behalf of PITER collaborating group.
Access to anti-HCV treatment with DAAs in the migrant population in Italy: data from the PITER cohort
ICAR 2018. X Italian conference on AIDS and Antiviral Research, Roma, 22-24 Maggio 2018

S Vella, L Kondili, A Marcellusi, R Viti, S Rosato, MG Quaranta, ME Tosti, L Ferrigno, F Mennini.
Epidemiological and economic evaluations according to DAA treatment access: an interim evaluation based on PITER cohort data
International Symposium on HIV and Emerging Infectious Diseases (ISHEID 2018), Marsiglia, 16-18 Maggio 2018.

S Robbins, LA Kondili, S Blach, I Gamkrelidze, AL Zignego, MR Brunetto, G Raimondo, G Taliani, A Iannone, FP Russo, T Santantonio, M Zuin, L Chessa, PL Blanc, M Puoti, M Vinci, EM Erne, M Strazzabosco, M Massari, P Lampertico, MG Rumi, A Federico, C Ferrari, A Ciancio, G Borgia, P Andreone, N Caporaso, M Persico, D Ieluzzi, A Gori, A Gasbarrini, C Coppola, GB Gaeta, A Andriulli, S Montilla, H Razavi, M Melazzini, S Vella, A Craxì on behalf of PITER collaborating group.
Forecasting liver disease burden based on a real life cohort of the linked to care patients in Italy. Does the “underwater portion of the iceberg” matter to reach the WHO HCV eliminating goals in the high HCV prevalent countries?
The International Liver Congress™ 2018. 53rd Annual meeting of the European Association for the Study of the Liver (EASL). Parigi 11-15 Aprile 2018

LA Kondili, MG Quaranta, S Rosato, M Monti, B Coco, R Filomia, E Biliotti, A Iannone, A Zanetto, S Bruno, A Giorgini, M Loi, F Baragli, C Baiguera, M Vinci, E Castelli, A Ciaccio, R Corsini, R D’Ambrosio, S Labanca, M Dallio, A Orlandini, A Ciancio, AR Buonomo, V Guarneri, V Cossiga, M Masarone, D Ieluzzi, M Cannizzaro, A Soria, M Siciliano, DC Amoruso, G Brancaccio, LE Weimer, L Ferrigno, ME Tosti, C Estes, H Razavi, V Calvaruso, on behalf of PITER collaborating group.
Multifactor risk evaluation in patients who have eradicated HCV infection: an interim analysis in the PITER cohort
The International Liver Congress™ 2018. 53rd Annual meeting of the European Association for the Study of the Liver (EASL). Parigi 11-15 Aprile 2018

S Robbins, LA Kondili, S Blach, I Gamkrelidze, AL Zignego, MR Brunetto, G Raimondo, G Taliani, A Iannone, FP Russo, T Santantonio, M Zuin, L Chessa, PL Blanc, M Puoti, M Vinci, EM Erne, M Strazzabosco, M Massari, P Lampertico, MG Rumi, A Federico, C Ferrari, A Ciancio, G Borgia, P Andreone, N Caporaso, M Persico, D Ieluzzi, A Gori, A Gasbarrini, C Coppola, S Madonia, GB Gaeta, A Andriulli, S Montilla, H Razavi, M Melazzini, S Vella, A Craxì on behalf of PITER collaborating group.
Forecasting liver disease burden based on a real life cohort of the linked to care patients in Italy. Does the “underwater portion of the iceberg” matter to reach the WHO HCV eliminating goals in the high HCV prevalent countries?
51st Annual Meeting of the Italian Association for the Study of the Liver. Roma 22, 23 Febbraio 2018

LA Kondili, MR Brunetto, G Taliani, AL Zignego, GB Gaeta, M Strazzabosco, G Raimondo, D Ieluzzi, A Iannone, P Andreone, TA Santantonio, A Craxì, FP Russo, M Puoti, G Borgia, M Zuin, M Siciliano, L Chessa, A Gori, M Massari, M Persico, F Morisco, P Blanc, A Federico, EM Erne, A Alberti, C Torti, MG Rumi, M Vinci, A Orlandini, G Montalto, A Giacometti, CM Mastroianni, I Serio, P Toniutto, A Aghemo, G Morsica, R Gulminetti, G Verucchi, J Vecchiet, F Castelli, V Zuccaro, A Benedetti, S Fargion, M Anselmo, M Galli, LE Weimer, S Rosato, MG Quaranta, S Vella.
Real life clinical outcomes in DAA-treated and untreated patients with HCV advanced liver disease. Interim one year data from the ongoing PITER cohort
The Liver Meeting, AASLD 2017. Washington, DC 20-24 Ottobre, 2017

LA Kondili, MR Brunetto, G Taliani, AL Zignego, GB Gaeta, M Strazzabosco, G Raimondo, D Ieluzzi, A Iannone, P Andreone, TA Santantonio, A Craxì, FP Russo, M Puoti, G Borgia, M Zuin, M Siciliano, L Chessa, A Gori, M Massari, M Persico, F Morisco, P Blanc, A Federico, EM Erne, A Alberti, C Torti, MG Rumi, M Vinci, A Orlandini, G Montalto, A Giacometti, CM Mastroianni, I Serio, P Toniutto, A Aghemo, G Morsica, R Gulminetti, G Verucchi, J Vecchiet, F Castelli, V Zuccaro, A Benedetti, S Fargion, M Anselmo, M Galli, LE Weimer, S Rosato, MG Quaranta, S Vella.
Real life clinical outcomes in DAA-treated and untreated patients with HCV advanced liver disease. Interim one year data from the ongoing PITER cohort
XVI Congresso Nazionale SIMIT, Salerno, 15-18 Ottobre, 2017

LA Kondili, GB Gaeta, MR Brunetto, D Ieluzzi, G Raimondo, R Filomia, AL Zignego, M Monti, B Coco, MG Rumi, A Di Leo, A Iannone, TA Santantonio, A Giammario, C Coppola, DC Amoruso, P Blanc, B Del Pin, L Chemello, L Cavalletto, F Morisco, L Donnarumma, A Gasbarrini, M Siciliano, M Massari, R Corsini, S Madonia, FP Russo, A Zanetto, M Persico, M Masarone, E Villa, V Bernabucci, G Taliani, E Biliotti, L Chessa, MC Pasetto, P Andreone, M Margotti, G Brancaccio, G Borgia, E Zappulo, V Calvaruso, S Petta, S Rosato, MG Quaranta, L Falzano, S Vella, EG Giannini.
DAA failure and clinical impact of retreatment in a real-life setting of patients with HCV-related advanced liver disease. Evaluation from the PITER network
XVI Congresso Nazionale SIMIT, Salerno, 15-18 Ottobre, 2017

M Ruggeri, F Romano, S Coretti, L Kondili, S Vella, FR Rolli, C Drago, A Cicchetti and PITER Collaborating Group.
Cost Effectiveness analysis of different health policies based on the second generation DAA-IFN free regimens in an Italian population
12th World Congress of the International Health Economics Association. Boston 7-11 Giugno, 2017

M Ruggeri, F Romano, S Coretti, L Kondili, S Vella, FR Rolli, C Drago, A Cicchetti and PITER Collaborating Group.
Cost Effectiveness analysis of different health policies based on the second generation DAA-IFN free regimens in an Italian population
2017 iHEA World Congress – Revolutions in the Economics of Health Systems. Roma 17-21 Giugno, 2017

LA Kondili, M Monti, V Rizzo, E Zappulo, L Chemello, M Vinci, M Margotti, M Puoti, M Persico, S Madonia, B Coco, D Ieluzzi, MG Rumi, R Corsini, G Lazzarini, E Biliotti, C Cerva, M Gonzo, A Federico, AL Zignego.
Diagnostic and IFN-Free therapeutic spproach of HCV+ Mixed Cryoglobulinemia in PITER (Piattaforma Italiana per lo Studio della Terapia delle Epatiti Virali) Cohort
The 4th International Congress on Controversies in Rheumatology & Autoimmunity, CORA 2017, Bologna 9-11 Marzo 2017

LA Kondili, M Monti, GB Gaeta, V Rizzo, G Borgia, E Zappulo, L Chemello, L Cavalletto, M Vinci, S Palladini, P Andreone, M Margotti, M Puoti, E Danieli, M Persico, M Masarone, S Madonia, , MR Brunetto, B Coco, D Ieluzzi, N Passigato, MG Rumi, V Sciola, M Massari, R Corsini, G Mazzella, G Lazzarini, G Taliani, E Biliotti, M Andreoni, C Cerva, A Alberti, M Gonzo, L Chessa, MC Pasetto, A Federico, M Dallio, MG Quaranta, LE Weimer, S Vella, AL Zignego.
Diagnostic and therapeutic approaches of Mixed Cryoglobulinemia in PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort
The International Liver Congress™ 2017. 52nd annual meeting of the European Association for the Study of the Liver (EASL). Amsterdam 19-23 Aprile 2017

L Kondili, A Di Leo, A Iannone, T Santantonio, A Giammario, G Raimondo, R Filomia, C Coppola, D Amoruso, P Blanc, B Del Pin, L Chemello, L Cavalletto, F Morisco, L Donnarumma, MG Rumi, A Gasbarrini, M Siciliano, M Massari, R Corsini, MR Brunetto, B Coco, S Madonia, AL Zignego, M Monti, FP Russo, A Zanetto, M Persico, M Masarone, E Villa, V Bernabucci, G Taliani, E Biliotti, L Chessa, MC Pasetto19, P Andreone, M Margotti, GB Gaeta, V Rizzo, D Ieluzzi, G Borgia, E Zappulo, V Calvaruso, S Petta, FR Rolli, L Falzano, S Rosato, M Ruggeri.
Clinical characterization and economic impact evaluation of anti- HCV DAA treatment failure: real life data from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER)
The International Liver Congress™ 2017. 52nd annual meeting of the European Association for the Study of the Liver (EASL). Amsterdam 19-23 Aprile 2017

LA Kondili, F Romano, M Ruggeri, S Rosato, MR Brunetto, AL Zignego, A Ciancio, A Di Leo, G Raimondo, C Ferrari, G Taliani, G Borgia, TA Santantonio, P Blanc, GB Gaeta, A Gasbarrini, L Chessa, EM Erne, E Villa, D Ieluzzi, FP Russo, P Andreone, M Vinci, C Coppola, L Chemello, S Madonia, G Verucchi, M Persico, M Zuin, M Puoti, A Alberti, G Nardone, V De Maria, M Massari, G Montalto, G Foti, MG Rumi, A Cicchetti, A Craxì, S Vella.
Health gains and costs of HCV treatment: a cost effectiveness analysis of two different health policies scenarios simulated in PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) real life cohort
The Liver Meeting, AASLD 2016. Boston 11-15 Novembre 2016. (POSTER of DISTINCTION)

S Rosato, LA Kondili, MG Quaranta, LE Weimer, L Falzano, A Mallano, ME Tosti, M Massella, S Vella e il gruppo di coordinamento del Progetto PITER.
Priorità del trattamento secondo l’algoritmo EASL HCV CPG 015: una valutazione real-life sulla coorte PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali)
40° Congresso AIE 2016 – Le evidenze in epidemiologia: una storia lunga 40 anni, Torino 19-21 Ottobre 2016

LA Kondili, F Romano, M Ruggeri, S Rosato, MR Brunetto, AL Zignego, A Ciancio, A Di Leo, G Raimondo, C Ferrari, G Taliani, G Borgia, TA Santantonio, P Blanc, GB Gaeta, A Gasbarrini, L Chessa, EM Erne, E Villa, D Ieluzzi, FP Russo, P Andreone, M Vinci, C Coppola, L Chemello, S Madonia, G Verucchi, M Persico, M Zuin, M Puoti, A Alberti, G Nardone, V De Maria, M Massari, G Montalto, G Foti, MG Rumi, A Cicchetti, A Craxì, S Vella and PITER Collaborating Group.
Health gains and costs of HCV treatment: a cost-effectiveness analysis of two different health policies scenarios simulated in PITER (Piattaforma italiana per lo studio della terapia delle epatiti virali) real life cohort
XV Congresso Nazionale SIMIT, Baveno 16-19 Ottobre 2016

LA Kondili, L. Falzano, A Di Leo, A Iannone, T Santantonio, A Giammario, G Raimondo, R Filomia, C Coppola, D Amoruso, P Blanc, B Del Pin, L Chemello, L Cavalletto, F Morisco, L Donnarumma, MG Rumi, A Gasbarrini, M Siciliano10, M Massari, R Corsini, MR Brunetto, B Coco, S Madonia, AL Zignego, M Monti, FP Russo, E Franceschet, M Persico, M Masarone, E Villa, V Bernabucci, G Taliani, E Biliotti, L Chessa, MC Pasetto, P Andreone, M Margotti, GB Gaeta, V Rizzo, D Ieluzzi, V Calvaruso, S Petta, FR Rolli, F Romano, M Ruggeri and PITER Collaborating Group.
Clinical characterization and economic impact evaluation of anti-HCV DAA treatment failure: real life data from the Italian platform for the study of viral hepatitis therapies (PITER)
XV Congresso Nazionale SIMIT, Baveno 16-19 Ottobre 2016

MG Quaranta, G Brancaccio, S Fargion, L Valenti, A Giacometti, D Drenaggi, A Benedetti, MG Faraci, C Torti, A Strazzulla, G Angarano, M Milella, C Mastroianni, T Thieghi, P Toniutto, M Colombo, M Borghi, A Gori, E Cappelletti, F Castelli, S Zaltron, A Lazzarin, S Salpietro, F Rosina, L Framarin, C Viscoli, LA Nicolini, N Coppola, C Monari, R Gulminetti, A Gatti Comini, D Bartolozzi, E Salomoni, L Bolondi, F Baldelli, F Di Candilo, GB Gaeta and PITER Collaborating Group.
Difference in age distribution of the three major HCV genotypes in Italy and impact on comorbidities. analysis of the PITER cohort
XV Congresso Nazionale SIMIT, Baveno 16-19 Ottobre 2016

LA Kondili, L Falzano, A Di Leo, A Iannone, T Santantonio, A Giammario, G Raimondo, R Filomia, C Coppola, D Amoruso, P Blanc, B Del Pin, L Chemello, L Cavalletto, F Morisco, L Donnarumma, MG Rumi, A Gasbarrini, M Siciliano, M Massari, R Corsini, MR Brunetto, B Coco, S Madonia, AL Zignego, M Monti, FP Russo, E Franceschet, M Persico, M Masarone, E Villa, V Bernabucci, G Taliani, E Biliotti, L Chessa, MC Pasetto, P Andreone, M Margotti, GB Gaeta, V Rizzo, D Ieluzzi, V Calvaruso, S Petta and PITER Collaborating Group.
Clinical characterization and economic impact evaluation of anti-HCV DAA treatment failure: real life data from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER)
EASL Special Conference. Parigi 23-24 Settembre 2016

B Coco on behalf of PITER and ICONA/HepaICONA Studies.
Clinical and virological characteristics of HIV and HCV coinfected versus HCV monoinfected patients: real life evaluation in PITER and ICONA/HepaICONA Italian cohorts
ICAR 2016. VIII Italian conference on AIDS and Antiviral Research, Milano, 6-8 Giugno 2016

A Cozzi Lepri on behalf of PITER and ICONA/HepaICONA Studies.
Access to new generation DAA treatment in HIV-negative and HIV-positive individuals with F3-F4 stage of liver disease: results from PITER and Icona/HepaICONA cohorts ICAR 2016
VIII Italian conference on AIDS and Antiviral Research, Milano, 6-8 Giugno 2016

L Kondili, MG Quaranta, L Falzano, M Di Gregorio, M Brunetto, AL Zignego, A Ciancio, A Di Leo, M Rendina, G Raimondo, C Ferrari, A Craxì, G Taliani, G Borgia, I Gentile, TA Santantonio, A Giammario, P Blanc, GB Gaeta, A Gasbarrini, M Siciliano, L Chessa, EM Erne, D Ieluzzi, FP Russo, P Andreone, M Vinci, C Coppola, L Chemello, S Madonia, G Verucchi, M Persico, M Zuin, A Alberti, M Puoti, G Nardone, V De Maria, M Massari, G Montalto, G Foti, MG Rumi, A Giacometti, A Benedetti, G D’Offizi, M Strazzabosco, S Fargion, G Angarano, A Federico, N Caporaso, C Mastroianni, P Toniutto, M Colombo, A Lazzarin, C Torti, M Andreoni, F Rosina, C Viscoli, S Vella, E Villa and PITER collaborating Group.
Gender differences in HCV chronic liver disease: a real life evaluation in PITER (Piattaforma Italiana Per Lo Studio Della Terapia Delle Epatiti Virali) Cohort Study. The International Liver Congress™ 2016
51st annual meeting of the European Association for the Study of the Liver (EASL). Barcellona, 13-17 Aprile 2016

L Kondili, LE Weimer, A Mallano, L Fucili, M Massella, M Vinci, G Borgia, M Brunetto, L Sturace, GB Gaeta, L Chemello, P Andreone, G Raimondo, R Filomia, M Persico, M Puoti, MG Rumi, A Benedetti, S Fargion, D Ieluzzi, G Nardone, G Foti, A Ciancio, G Taliani, E Biliotti,S Madonia, B Stagno, A Alberti, M Massari, F Rosina, G Mazzella, A Di Leo, A Iannone, C Ferrari, A Orlandini, M Monti, TA Santantonio, L Chessa, EM Erne, C Coppola, M Andreoni, F Baldelli, M Mondelli,P Blanc, A Gasbarrini, G Verucchi, M Colombo, M Borghi, A Craxì, S Petta, E Villa, O Patti, FP Russo, M Strazzabosco, S Vella, AL Zignego.
HCV-related mixed cryoglobulinemia: data from PITER, a nationwide Italian HCV cohort study. The International Liver Congress™ 2016
51st annual meeting of the European Association for the Study of the Liver (EASL). Barcellona, 13-17 Aprile 2016

ISS and AISF and SIMIT PITER Collaborating Group.
Clinical and virological profile of patients with diagnosed HCV chronic infection in Italy: data from PITER cohort study
49th Annual Meeting of the Italian Association for the Study of the Liver. Roma 18-19 Febbraio 2016

LE Weimer, M Vinci, G Borgia, M Brunetto, L Sturace, GB Gaeta, L Chemello, A Buggio, P Andreone, G Raimondo, R Filomia, M Persico, M Puoti, MG Rumi, A Benedetti, S Fargion, D Ieluzzi, G Nardone, G Foti, A Ciancio, G Taliani, E Biliotti, S Madonia, B Stagno, A Alberti, M Massari, F Rosina, G Mazzella, A Di Leo, A Iannone, C Ferrari, A Orlandini, L Gragnani, TA Santantonio, L Chessa, EM Erne, C Coppola, M Andreoni, F Baldelli, M Mondelli, P Blanc, A Gasbarrini, F D’Aversa, G Verucchi, M Colombo, M Borghi, A Craxì, S Petta, E Villa, O Patti, FP Russo, M Strazzabosco, A Mallano, L Fucili, M Massella1, L Kondili, S Vella, AL Zignego and ISS&AISF &SIMIT collaborating Group in PITER.
HCV-related mixed cryoglobulinemia: data from PITER, a nationwide Italian HCV cohort study
49th Annual Meeting of the Italian Association for the Study of the Liver. Roma 18-19 Febbraio 2016

M Brunetto, AL Zignego, A Ciancio, A Di Leo, M Rendina, G Raimondo, C Ferrari, A Craxì, G Taliani, G Borgia, I Gentile, TA Santantonio, P Blanc, GB Gaeta, A Gasbarrini, M Siciliano, L Chessa, EM Erne, D Ieluzzi, FP Russo, P Andreone, M Vinci, C Coppola, L Chemello, S Madonia, G Verucchi, M Persico, M Zuin, A Alberti, M Puoti, G Nardone, V De Maria, M Massari, G Montalto, G Foti, MG Rumi, A Giacometti, A Benedetti, G D’Offizi, M Strazzabosco, S Fargion, G Angarano, A Federico, N Caporaso, C Mastroianni, P Toniutto, M Colombo, A Lazzarin, C Torti, M Andreoni, F Rosina, C Viscoli,L Falzano, L Kondili, MG Quaranta, M Di Gregorio, S Vella, E Villa and ISS&AISF&SIMIT collaborating Group in PITER.
Gender differences in HCV chronic liver disease: A real life evaluation in PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort study
49th Annual Meeting of the Italian Association for the Study of the Liver. Roma 18-19 Febbraio 2016

P Colombatto, E Biliotti, D Palazzo, A Ciancio, B Del Pin, V Rizzo, G Brancaccio, MC Pasetto, E Castelli, D Ieluzzi, E Franceschet, S Storato, M Margotti, E Castelli, S Palladini, DC Amoruso, A Buggio, S Madonia, C Cerva, D Bartolozzi, F Castelli, R Gulminetti, G Mazzella, L Bolondi, F Baldelli, M Angelico, R Bruno, A Gori, G D’Adamo, G Leandro, J Vecchiet, A Picardi, V Vullo, M Libanore, N Coppola, A Grieco, L Raffaele, M Mondelli, R Cauda, M Galli, G Di Perri, A Floreani, A D’Arminio Monforte, MG Quaranta, L Kondili, S Rosato, M Mirra, ME Tosti, S Vella and ISS&AISF&SIMIT Collaborating Group in PITER.
Clinical and virological characteristics of HIV and HCV co-infected versus HCV monoinfected patients: a real-life evaluation in the PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort
49th Annual Meeting of the Italian Association for the Study of the Liver. Roma 18-19 Febbraio 2016

LA Kondili, S Rosato, MG Quaranta, LE Weimer, L Falzano, A Mallano, ME Tosti, M Massella, MR Brunetto, AL Zignego, M Rizzetto, A Di Leo, G Raimondo, C Ferrari, G Taliani, P Blanc, A Gasbarrini, L Chessa, EM Erne, G Fattovich, P Andreone, M Vinci, FP Russo, E Villa, GB Gaeta, T A Santantonio, G Borgia, G Verucchi, C Coppola, M Persico, L Chemello, A Alberti, V De Maria, M Puoti, R Bruno, P Caraceni, M Andreoni, M Marzioni, S Vella, A Craxì on the behalf of PITER Collaborating Group.
Treatment priotization according to the EASL HCV CPG: a real life evaluation on the PITER
The Liver Meeting – AASLD 2015, San Francisco, 13-17 Novembre 2015

LA Kondili, S Rosato, LE Weimer, MG Quaranta, L Falzano, A Mallano, ME Tosti, M Massella, MR Brunetto, AL Zignego, M Rizzetto, A Di Leo, G Raimondo, C Ferrari, A Craxì, G Taliani, P Blanc, A Gasbarrini, L Chessa, EM Erne, G Fattovich, P Andreone, M Vinci, FP Russo, E Villa, GB Gaeta, TA Santantonio, G Borgia, G Verucchi, C Coppola, M Persico, L Chemello, A Alberti, V De Maria, M Puoti, R Bruno, P Caraceni, M Andreoni, M Marzioni, S Vella on the behalf of PITER Collaborating Group.
Male gender, genotype 3, previous alcohol use, increased BMI, and diabetes are factors independently correlated to advanced HCV chronic liver disease in Italy: data from PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort study
The Liver Meeting – AASLD 2015, San Francisco, 13-17 Novembre 2015

LA Kondili, M Brunetto, AL Zignego, M Rizzetto, A Di Leo, G Raimondo, A Orlandini, A Craxì, S Vella and PITER Collaborating Group.
Italian Platform for The Study Of Viral Hepatitis Therapies (PITER): A Useful Real Life Framework To Evaluate DAAs Cost-Effectiveness And Guide Evidence-Based Health Policy
8° Congresso Nazionale SIHTA. Roma 1-3 Ottobre 2015

A Orlandini, C Ferrari, G Taliani, E Biliotti, G Montalto, AR Capitano, A Giacometti, P Castelli, S Fargion, L Valenti, G Angarano, M Milella, S Madonia, B Stagno, M Andreoni, N Cesta, D Bartolozzi, E Salomoni, C Torti, V Pisani, A Gori, S Costarelli, J Vecchiet, K Falasca, M Libanore, D Segala, S Rosato, L Falzano, MG Quaranta and PITER Collaborating Group.
Factors that influence HCV related liver disease severity in Italian patients in care: data from PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti ViRali) HCV cohort study”
XIV Congresso SIMIT, Catania, 8-11 Novembre 2015

P Blanc, B Del Pin Barbara, EM Elke, D Piovan, G Borgia, I Gentile, G Verucchi, L Badia, M Puoti, E Danieli, D Ieluzzi, S Storato, TA Santantonio, M Ciarallo, C Mastroianni, T Tieghi , G Foti, S Pellicano, A Lazzarin, S Salpietro, C Viscoli, A Di Biagio, F Castelli, S Odolini Silvia, F Baldelli, F Di Candilo, R Gulminetti, A Gatti Comini, A Mallano, M Massella, LE Weimer and PITER Collaborating Group.
Clinical and virological characteristics of HIV and HCV co-infected versus HCV mono-infected patients: a real-life evaluation in the PITER cohort
XIV Congresso Nazionale SIMIT, Catania, 8-11 Novembre 2015

LE Weimer, L Falzano, A Mallano, MG Quaranta, M Massella, S Rosato, P Colombatto, L Giubilei, A Ciancio, A Iannone, R Filomia, A Orlandini, S Petta, F Tamburrini, P Blanc, F D’Aversa, MC Pasetto, ME Erne, D Ieluzzi, S Storato, M Margotti, M Vinci, G Gottardo, O Patti, V Rizzo, A Giammario, I Gentile, V Donati, L Staiano, M Masarone, D Sterrantino, M Gonzo, F Giancotti, E Danieli, R Corsini, MG Faraci, L Valenti, M Cappelletti, S Camera, S Pellicano, B Stagno, T Tieghi, M Milella, M Dallio, A Rocco, M Borghi, D Drenaggi, S Zaltron, S Salpietro, L Framarin, AR Capitano, C Cerva, A Di Biagio, LA Kondili and PITER Collaborating Group.
NAFLD: a cofactor or bystander on HCV disease progression? Baseline results from patients enrolled in the PITER cohort study
Monotematica AISF: “NASH malattia epatica, oncologica e cardiovascolare”. Modena 8-10 Ottobre 2015

LE ULTIME NEWS

Epatite C: lo screening dell’infezione non è una spesa ma un investimento per la salute

L’epatite C rappresenta un problema di salute globale con gravi implicazioni umane, sociali ed economiche, specialmente in Italia, dove il tasso di mortalità è storicamente alto.

Il 28 luglio la giornata delle epatiti, causano 1,3 milioni di morti ogni anno nel mondo. Problema di grande impatto anche in Italia

Lo screening esteso a tutta la popolazione adulta italiana potrebbe portare in 10 anni ad una riduzione significativa di scompensi epatici, epatocarcinomi, decessi.